Net Asset Value, Corporate Update & Dividend

Summary by AI BETAClose X

Target Healthcare reported EPRA NTA per share up 0.9% to 123.2p at 30 September 2026 (total accounting return 2.1% for the quarter), driven by a 0.6% like‑for‑like valuation uplift from inflation‑linked rent reviews and contractual rent of £61.5m; adjusted EPRA EPS was 1.69p and the Company declared a fully covered quarterly dividend of 1.553p (up 3.0%). The portfolio value rose to £930.2m, net LTV remained low at 16.2% with committed facilities of £280m (£200m drawn) and weighted average cost on drawn debt 3.88%, and available capital c.£73m (plus up to £70m accordion).

Disclaimer*

UK 100

Latest directors dealings